Program

23
2
1

Journal Year Published

2
2
2
3
6
3
3
2
1
1

Author

25
202
181
149
140
133
133
125
123
108
105
95
82
78
64
63
55
50
46
43
43

Category

19
5
5
3
1

Keyword

7
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1

Journal

3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1

NCATS Publications

Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.


Mazzulli JR, Zunke F, Tsunemi T, Toker NJ, Jeon S, Burbulla LF, Patnaik S, Sidransky E, Marugan J, Sue CM, Krainc D


J. Neurosci. , (36), 7693-706, 2016.

Article Pubmed

Sample image from publication page

A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.


Aflaki E, Borger DK, Moaven N, Stubblefield BK, Rogers SA, Patnaik S, Schoenen FJ, Westbroek W, Zheng W, Sullivan P, Fujiwara H, Sidhu R, Khaliq ZM, Lopez GJ, Goldstein DS, Ory DS, Marugan J, Sidransky E


J. Neurosci. , (36), 7441-52, 2016.

Article Pubmed

Sample image from publication page

MCOLN1 is a ROS sensor in lysosomes that regulates autophagy.


Zhang X, Cheng X, Yu L, Yang J, Calvo R, Patnaik S, Hu X, Gao Q, Yang M, Lawas M, Delling M, Marugan J, Ferrer-Alegre M, Xu H


Nat Commun , (7), 12109, 2016.

Article Pubmed

Sample image from publication page

Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages.


Aflaki E, Moaven N, Borger DK, Lopez G, Westbroek W, Chae JJ, Marugan J, Patnaik S, Maniwang E, Gonzalez AN, Sidransky E


Aging Cell , (15), 77-88, 2016.

Article Pubmed

Sample image from publication page

Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.


Aflaki E, Stubblefield BK, Maniwang E, Lopez G, Moaven N, Goldin E, Marugan J, Patnaik S, Dutra A, Southall N, Zheng W, Tayebi N, Sidransky E


Sci Transl Med , (6), 240ra73, 2014.

Article Pubmed

Sample image from publication page

Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects.


Hoskins JW, Ofori LO, Chen C, Kumar A, Sobczak K, Nakamori M, Southall N, Patnaik S, Marugan J, Zheng W, Austin C, Disney MD, Miller BL, Thornton CA


Nucleic Acids Res. , (42), 6591-602, 2014.

Article Pubmed

Sample image from publication page

Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.


Krueger AB, Drasin DJ, Lea WA, Patrick AN, Patnaik S, Backos DS, Matheson CJ, Hu X, Barnaeva E, Holliday MJ, Blevins MA, Robin TP, Eisenmesser EZ, Ferrer-Alegre M, Simeonov A, Southall N, Reigan P, Marugan J, Ford HL, Zhao R


J. Biol. Chem. , (289), 16349-61, 2014.

Article Pubmed

Sample image from publication page

Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.


Patnaik S, Marugan J, Liu K, Zheng W, Southall N, Dehdashti SJ, Thorsell A, Heilig M, Bell L, Zook M, Eskay B, Brimacombe K, Austin C


J. Med. Chem. , (56), 9045-56, 2013.

Article Pubmed

Sample image from publication page

Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.


Childs-Disney JL, Stepniak-Konieczna E, Tran T, Yildirim I, Park H, Chen C, Hoskins J, Southall N, Marugan J, Patnaik S, Zheng W, Austin C, Schatz GC, Sobczak K, Thornton CA, Disney MD


Nat Commun , (4), 2044, 2013.

Article Pubmed

Sample image from publication page